1192 related articles for article (PubMed ID: 25220870)
1. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
4. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
[TBL] [Abstract][Full Text] [Related]
5. Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction.
Kim MJ; Yun HS; Hong EH; Lee SJ; Baek JH; Lee CW; Yim JH; Kim JS; Park JK; Um HD; Hwang SG
Cancer Lett; 2013 Oct; 339(1):15-24. PubMed ID: 23900080
[TBL] [Abstract][Full Text] [Related]
6. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
[TBL] [Abstract][Full Text] [Related]
7. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
Wong JC; Bathina M; Fiscus RR
J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
[TBL] [Abstract][Full Text] [Related]
9. Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression.
Wang HQ; Jin JJ; Wang J
J Biochem Mol Toxicol; 2014 Jan; 28(1):39-45. PubMed ID: 24395429
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer.
Song J; Shu L; Zhang Z; Tan X; Sun E; Jin X; Chen Y; Jia X
Chem Biol Interact; 2012 Jul; 199(1):9-17. PubMed ID: 22687635
[TBL] [Abstract][Full Text] [Related]
11. An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.
Vanajothi R; Srinivasan P
J Recept Signal Transduct Res; 2016; 36(3):292-302. PubMed ID: 26585176
[TBL] [Abstract][Full Text] [Related]
12. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.
Azijli K; van Roosmalen IA; Smit J; Pillai S; Fukushima M; de Jong S; Peters GJ; Bijnsdorp IV; Kruyt FA
Cancer Chemother Pharmacol; 2014 Jun; 73(6):1273-83. PubMed ID: 24744163
[TBL] [Abstract][Full Text] [Related]
13. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
14. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
15. Zerumbone protects INS-1 rat pancreatic beta cells from high glucose-induced apoptosis through generation of reactive oxygen species.
Wang C; Zou S; Cui Z; Guo P; Meng Q; Shi X; Gao Y; Yang G; Han Z
Biochem Biophys Res Commun; 2015 May; 460(2):205-9. PubMed ID: 25769956
[TBL] [Abstract][Full Text] [Related]
16. Tea polyphenols modulate antioxidant redox system on cisplatin-induced reactive oxygen species generation in a human breast cancer cell.
Periasamy VS; Alshatwi AA
Basic Clin Pharmacol Toxicol; 2013 Jun; 112(6):374-84. PubMed ID: 23145928
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549.
Kamal A; Nayak VL; Bagul C; Vishnuvardhan MV; Mallareddy A
Apoptosis; 2015 Nov; 20(11):1518-29. PubMed ID: 26386574
[TBL] [Abstract][Full Text] [Related]
18. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.
Wu SH; Hang LW; Yang JS; Chen HY; Lin HY; Chiang JH; Lu CC; Yang JL; Lai TY; Ko YC; Chung JG
Anticancer Res; 2010 Jun; 30(6):2125-33. PubMed ID: 20651361
[TBL] [Abstract][Full Text] [Related]
19. Combination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: A reactive oxygen species and P-p38 mediated mechanism.
Hou XB; Li TH; Ren ZP; Liu Y
Biomed Pharmacother; 2016 Dec; 84():1575-1584. PubMed ID: 27825799
[TBL] [Abstract][Full Text] [Related]
20. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
